Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MDGL compared with ARGX: revenue, margins and what each company keeps, and the suppliers and customers both name
MDGL
Madrigal Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
ARGX
Argenx SE
Change
Mkt cap
Revenue
Revenue
vs
Compare
MDGL
Madrigal Pharmaceuticals, Inc.
vs
ARGX
Argenx SE
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
MDGL, solid
ARGX, dashed
MDGL
Madrigal Pharmaceuticals, Inc.
Change
428.69
▼
−0.39%
Mkt cap
$9.9B
Revenue
$364M
Q2 FY26
Revenue
$958M
FY25
ARGX
Argenx SE
Change
884.04
▼
−0.99%
Regular session
Sep 2 '83
Mkt cap
$55.3B
Revenue
—
Revenue
—
vs
Compare
Regular session
Sep 2 '83
MDGL
Madrigal Pharmaceuticals, Inc.
vs
ARGX
Argenx SE
428.69
▼
−0.39%
Price
884.04
▼
−0.99%
$9.9B
Mkt cap
$55.3B
Q2 FY26
$364M
Revenue
—
FY25
$958M
Revenue
—
Change
Change
MDGL
428.69
▼
−0.39%
vs
ARGX
884.04
▼
−0.99%
Regular session
Sep 2 '83